Biogen’s Alzheimer’s drug approval could pave the way for major changes across the industry. Read More
Related Articles
Investors dump stocks, gold and crypto as suddenly everything looks expensive
Posted on Author admin
The question remains: can we call this too a “transitory” move? Read More
Friday feedback: Parsing the Danone drama
Posted on Author admin
Emmanuel Faber’s ejection revives the stakeholder capitalism debate. Read More
COVID-19 vaccine rollout Begins from the US
Posted on Author admin
Expand / NEW YORK, NY – DECEMBER 14: Sandra Lindsay, abandoned, a nurse at Long Island Jewish Medical Center, is pleased with the COVID-19 vaccine by Dr. Michelle Chester from the Queens borough of Nyc. In the aftermath of positive outcomes from big scale trials, lots of states are embracing the COVID-19 vaccine created by […]